American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$460M |
| 2 |
Broadcom
AVGO
|
+$298M |
| 3 |
Sysco
SYY
|
+$225M |
| 4 |
MRSH
Marsh
MRSH
|
+$200M |
| 5 |
Ascendis Pharma A/S
ASND
|
+$186M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$573M |
| 2 |
Visa
V
|
+$465M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$363M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$358M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.8% |
| 2 | Financials | 13.6% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Industrials | 10.05% |
| 5 | Healthcare | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
National Presto Industries
NPK
$998M
| $1.54M | ﹤0.01% |
14,395
+3
| +0% | +$314 |
|
2177
Simply Good Foods
SMPL
$968M
| $1.53M | ﹤0.01% |
76,316
+9,251
| +14% | +$193K |
|
2178
Perrigo
PRGO
$1.76B
| $1.53M | ﹤0.01% |
109,912
+70,312
| +178% | +$1.17M |
|
2179
Schwab International Small-Cap Equity ETF
SCHC
$5.69B
| $1.53M | ﹤0.01% |
33,567
-40,087
| -54% | -$1.82M |
|
2180
Hims & Hers Health
HIMS
$6.71B
| $1.52M | ﹤0.01% |
46,851
+5,756
| +14% | +$247K |
|
2181
Universal Display
OLED
$4.18B
| $1.52M | ﹤0.01% |
12,987
+107
| +0.8% | +$13.9K |
|
2182
Matthews International
MATW
$725M
| $1.51M | ﹤0.01% |
57,978
-12,647
| -18% | -$311K |
|
2183
Washington Trust Bancorp
WASH
$750M
| $1.51M | ﹤0.01% |
51,065
-33
| -0.1% | -$939 |
|
2184
ScottsMiracle-Gro
SMG
$3.62B
| $1.5M | ﹤0.01% |
25,766
+14,257
| +124% | +$800K |
|
2185
Ascent Industries
ACNT
$133M
| $1.5M | ﹤0.01% |
92,799
+30,878
| +50% | +$425K |
|
2186
BCB Bancorp
BCBP
$161M
| $1.5M | ﹤0.01% |
185,541
-1,407
| -0.8% | -$11.4K |
|
2187
BOK Financial
BOKF
$8.85B
| $1.5M | ﹤0.01% |
12,630
+225
| +2% | +$25.2K |
|
2188
Carrier Global
CARR
$52.2B
| $1.49M | ﹤0.01% |
28,264
-58,774
| -68% | -$3.27M |
|
2189
First Watch Restaurant Group
FWRG
$800M
| $1.48M | ﹤0.01% |
98,416
+6,763
| +7% | +$114K |
|
2190
AMN Healthcare
AMN
$1.34B
| $1.48M | ﹤0.01% |
93,989
-1,184
| -1% | -$21.1K |
|
2191
Kanzhun
BZ
$7.19B
| $1.48M | ﹤0.01% |
72,512
+1,104
| +2% | +$23.9K |
|
2192
Cullinan Oncology
CGEM
$1.26B
| $1.48M | ﹤0.01% |
142,761
+1,692
| +1% | +$15.3K |
|
2193
Integra LifeSciences
IART
$1.35B
| $1.48M | ﹤0.01% |
118,906
+7,312
| +7% | +$97.2K |
|
2194
Neogen
NEOG
$2.5B
| $1.46M | ﹤0.01% |
209,044
+67,891
| +48% | +$427K |
|
2195
Viper Energy
VNOM
$15.2B
| $1.45M | ﹤0.01% |
37,451
-23,052
| -38% | -$873K |
|
2196
Ramaco Resources Class A
METC
$692M
| $1.44M | ﹤0.01% |
80,051
-766,057
| -91% | -$20.1M |
|
2197
Replimune Group
REPL
$1.43B
| $1.44M | ﹤0.01% |
148,086
+8,350
| +6% | +$71K |
|
2198
Tootsie Roll Industries
TR
$3.02B
| $1.44M | ﹤0.01% |
40,467
+2,098
| +5% | +$79.5K |
|
2199
Fulgent Genetics
FLGT
$515M
| $1.44M | ﹤0.01% |
54,731
-3,925
| -7% | -$102K |
|
2200
Cytek Biosciences
CTKB
$621M
| $1.44M | ﹤0.01% |
284,644
+7,658
| +3% | +$35.6K |
|
Similar funds
American Century Companies's Q4 2025 Portfolio in Review
As of Q4 2025, American Century Companies held 2,902 positions worth $199B, up 1.2% from $197B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q4 2025 filing shows 123 new, 1,653 increased, 947 reduced and 91 closed positions. Its largest new stake was Amrize Ltd: 2,173,524 shares worth $118M. The largest sale was NVIDIA, an estimated $573M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- American Century Companies's largest Q4 2025 buy was Amrize Ltd: 2,173,524 shares worth $118M.
- American Century Companies added most to Amphenol in Q4 2025, an estimated $460M increase.
- American Century Companies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $573M.
- American Century Companies fully exited Premier in Q4 2025, selling an estimated $91.5M.
- American Century Companies's ten largest holdings make up 27% of its $199B portfolio in Q4 2025.
- American Century Companies opened 123 new positions and closed 91 in Q4 2025.
- American Century Companies's portfolio value rose 1.2% quarter-over-quarter to $199B.
Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.